Bermekimab (IL1A) - Research Grade Biosimilar
Product Specifications
Background
Bermekimab is under investigation in clinical trial NCT01384630 (Safety, Pharmacokinetics, and Efficacy of RA-18C3 in Subjects With Moderate to Severe Psoriasis) .
Immunogen
Humanized / IL1A [Homo sapiens]
Clonality
Recombinant Monoclonal
Conjugation
Unconjugated
Type
Primary Antibodies, Biosimilars
Source
CHO cells
Field of Research
Cancer
Purification
>95%
Concentration
Batch dependent
Buffer
PBS buffer pH7.5
Modification
None
Shipping Conditions
Blue Ice
Storage Conditions
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.
Fragment
IgG1-kappa
NCBI Organism
Homo sapiens
Other Product Names
MABp1, Xilonix
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
NBL1-09116 0.1 mg
Centrin 2 Overexpression Lysate (Native) - (Dry Ice)
Sign In for Pricing
View Details 
bsm-61194R-BF405-TR 20 µL
Phospho-Histone H2A (Ser129) Recombinant Antibody, AbBy Fluor™ 405 Conjugated
Sign In for Pricing
View Details 
35001151 3x 1.0 µg DNA
OR1I1 CRISPR All-in-one AAV vector set (with saCas9)(Human)
Sign In for Pricing
View Details 
OR95480-01 500 mg
Methyl 3,3-dimethyl-1,2,3,4-tetrahydro-1,3-azasiline-5-carboxylate
Sign In for Pricing
View Details